Boehringer Ingelheim International GmbH et al v. MSN Laboratories Private Ltd. et al
| Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc. |
| MSN Pharmaceuticals Inc. and MSN Laboratories Private Ltd. |
| 1:2019cv01865 |
| October 3, 2019 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 29, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 11
SO ORDERED, re (8 in 1:19-cv-01866-CFC, 8 in 1:19-cv-01865-CFC, 8 in 1:19-cv-01885-CFC, 8 in 1:19-cv-01864-CFC, 127 in 1:18-cv-01689-CFC-SRF, 9 in 1:19-cv-01862-CFC) Stipulation. The New Cases shall be consolidated with the Consolidated Action for all purposes, and all papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). See Stipulations for further details and deadlines. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms)
|
| Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. (fms) |
| All papers shall be filed in C.A. No. 18-1689 (CFC) (consolidated). Associated Cases: 1:18-cv-01689-CFC-SRF et al.(fms) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Ltd. for MSN Pharmaceuticals Inc. filed by MSN Pharmaceuticals Inc.. (Phillips, John) |
| Filing 9 ANSWER to #1 Complaint, Affirmative Defenses and, COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by MSN Pharmaceuticals Inc., MSN Laboratories Private Ltd..(Phillips, John) |
| Filing 8 STIPULATION for Consolidation by Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., InvaGen Pharmaceuticals, Inc., Lupin Ltd., Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) |
| Filing 7 SUMMONS Returned Executed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc.. MSN Pharmaceuticals Inc. served on 10/8/2019, answer due 10/29/2019. (Blumenfeld, Jack) |
| Filing 6 SUMMONS Returned Executed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc.. MSN Laboratories Private Ltd. served on 10/8/2019, answer due 10/29/2019. (Blumenfeld, Jack) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:19-cv-01862-CFC, 1:19-cv-01864-CFC, 1:19-cv-01865-CFC, 1:19-cv-01866-CFC, 1:19-cv-01885-CFC (rjb) |
| Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Private Ltd. on 10/4/2019; MSN Pharmaceuticals Inc. on 10/4/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn Ag & Co. Kg for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (sam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,258,637 B2 (sam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 6, 2019. Date of Expiration of Patent: April 3, 2034.Thirty Month Stay Deadline: 2/1/2022. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT filed against MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2746795.) - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. (Attachments: #1 Exhibit 1, #2 Civil Cover Sheet)(sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
